Preliminary Study of Uterine Healing After Caesarean Section: CLInico-ECHOgraphic and Anatomopathologic COrrelation
NCT ID: NCT05785559
Last Updated: 2023-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
90 participants
INTERVENTIONAL
2023-04-01
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The processes of uterine healing at the histological scale are little known. The main objective of the research is to analyze the process of uterine healing by means of uterine biopsies performed on the areas of cesarean section scars.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mri in Evaluation of Cesarean Section Scar Niche
NCT03911622
Cesarean Section Scar Evaluation by Saline Contrast Sonohysterography During Hysteroscopy
NCT02865655
Ultrasound Study of the Uterine Healing Process After Cesarean Delivery
NCT00224250
Prevalence, Risk Factors and Consequences Related to Cesarean Scar Defect (Defect in Cesarean Scar)
NCT02717312
Lower Uterine Segment Following a Cesarean Section With Barbed Suture
NCT05166174
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of the research is to analyze uterine scarring by means of uterine biopsies performed on the areas of cesarean section scars. The uterine scarred areas will be analyzed histologically according to specific criteria and compared to healthy uterine areas. Histological characteristics will be compared with clinical and ultrasound data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scarred uterus
Patients who have already undergone one or more cesarean section(s) during a previous pregnancy and for whom a cesarean section is indicated on a scheduled or emergency basis.
uterine biopsies
uterine biopsies performed on the areas of cesarean section scars
Scar dehiscence surgery
Patients who have already undergone one or more caesarean section(s) and for whom the surgical management of a dehiscence of a caesarean section scar is indicated outside of pregnancy.
uterine biopsies
uterine biopsies performed on the areas of cesarean section scars
Healthy uterus
Patients with no history of caesarean section, pregnant with an indication for caesarean section: patients who have never had a caesarean section during a previous pregnancy or who are pregnant with their first pregnancy and for whom a caesarean section is indicated scheduled or urgently"
uterine biopsies
uterine biopsies performed on the areas of cesarean section scars
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterine biopsies
uterine biopsies performed on the areas of cesarean section scars
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patient,
* Signed consent for participation in the study
* Patient affiliated to a social security scheme (excluding AME)
Group 1:
* Support for a scheduled or emergency caesarean (excluding patients having an emergency caesarean (red code: caesarean within 15 minutes))
* Scarred uterus: having already benefited from a caesarean section
Group 2:
\- Surgical management of caesarean section scar dehiscence after a caesarean section
Group 3 (control):
* Support for a scheduled or emergency caesarean (excluding patients having an emergency caesarean (red code: caesarean within 15 minutes)
* Healthy uterus: no history of caesarean section (history of vaginal delivery or first pregnancy)
Exclusion Criteria
* Anatomopathological sampling not feasible
* Patient with a history of upper genital infections
* Patient under legal protection (guardianship, curatorship)
* Patient who does not speak or understand French
* Patient unable to answer questions or with difficulty in expressing herself
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Perrine CAPMAS
Role: PRINCIPAL_INVESTIGATOR
APHP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AP-HP, Bicêtre Hospital
Le Kremlin-Bicêtre, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP220952
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.